Suggested for -nE:
COMTQ - Overview: Catechol-O-Methyltransferase (COMT) Genotype, Varies
Prediction of response to nicotine replacement therapy for smoking cessation Investigation of inhibitor dosing for decreasing levodopa metabolism Research use for assessing estrogen metabolism
FCURV - Overview: Curvularia spicifera/Bipolaris IgE
Curvularia spicifera/Bipolaris IgE
DMC2 - Overview: Dementia, Autoimmune/Paraneoplastic Evaluation, Spinal Fluid
Investigating new onset dementia and cognitive impairment plus 1 or more of the following accompaniments using cerebrospinal fluid specimens: -Rapid onset and progression -Fluctuating course -Psychiatric accompaniments (psychosis,...
DIA - Overview: Diazepam and Nordiazepam, Serum
Assessing compliance Monitoring for appropriate therapeutic level Assessing diazepam toxicity
DMS2 - Overview: Dementia, Autoimmune/Paraneoplastic Evaluation, Serum
Investigating new onset dementia and cognitive impairment plus 1 or more of the following using serum specimens: -Rapid onset and progression -Fluctuating course -Psychiatric accompaniments (psychosis, hallucinations) -Movement disorder...
Establishing laboratory evidence of disseminated intravascular coagulation
DSGAB - Overview: Desmoglein 1 (DSG1) and Desmoglein 3 (DSG3), IgG Antibodies, Serum
Preferred screening test for patients suspected to have an autoimmune blistering disorder of the skin or mucous membranes (pemphigus) Aiding in the diagnosis of pemphigus
DYS2 - Overview: Dysautonomia, Autoimmune/Paraneoplastic Evaluation, Serum
Investigating idiopathic dysautonomic symptoms Directing a focused search for cancer in patients with idiopathic dysautonomia Investigating autonomic symptoms that appear in the course or wake of cancer therapy and are not explainable by...
DULOX - Overview: Duloxetine, Serum
Monitoring duloxetine serum concentration during therapy Evaluating potential duloxetine toxicity Evaluating patient compliance